CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $203 | -99.5% | 13,631 | +0.7% | 0.00% | – |
Q2 2022 | $40,000 | -68.0% | 13,535 | -66.4% | 0.00% | -100.0% |
Q1 2022 | $125,000 | +4.2% | 40,225 | +13.3% | 0.00% | +100.0% |
Q4 2021 | $120,000 | -4.0% | 35,495 | +23.6% | 0.00% | 0.0% |
Q2 2021 | $125,000 | +54.3% | 28,719 | +61.9% | 0.00% | 0.0% |
Q1 2021 | $81,000 | -44.1% | 17,739 | -11.2% | 0.00% | -66.7% |
Q3 2020 | $145,000 | -54.8% | 19,971 | -78.3% | 0.00% | -62.5% |
Q2 2020 | $321,000 | +146.9% | 91,992 | +407.1% | 0.01% | +60.0% |
Q2 2019 | $130,000 | -81.9% | 18,142 | -66.4% | 0.01% | -90.6% |
Q1 2019 | $717,000 | – | 54,003 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |